Advanced and relapsed/refractory Hodgkin lymphoma: what has been achieved during the last 50 years
about
Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent RegimensBrentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.Primary Epstein-Barr virus infection diffusing F18-fluorodeoxyglucose-positron emission tomography/computed tomography response monitoring of Hodgkin's disease: a case report.Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study.
P2860
Advanced and relapsed/refractory Hodgkin lymphoma: what has been achieved during the last 50 years
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Advanced and relapsed/refracto ...... ieved during the last 50 years
@ast
Advanced and relapsed/refracto ...... ieved during the last 50 years
@en
Advanced and relapsed/refracto ...... ieved during the last 50 years
@nl
type
label
Advanced and relapsed/refracto ...... ieved during the last 50 years
@ast
Advanced and relapsed/refracto ...... ieved during the last 50 years
@en
Advanced and relapsed/refracto ...... ieved during the last 50 years
@nl
prefLabel
Advanced and relapsed/refracto ...... ieved during the last 50 years
@ast
Advanced and relapsed/refracto ...... ieved during the last 50 years
@en
Advanced and relapsed/refracto ...... ieved during the last 50 years
@nl
P1476
Advanced and relapsed/refracto ...... ieved during the last 50 years
@en
P2093
Maria K. Angelopoulou
Theodoros P. Vassilakopoulos
P356
10.1053/J.SEMINHEMATOL.2013.02.002
P407
P577
2013-01-01T00:00:00Z